Publications - Winston Tan, M.D.

Back to Research Profile

1. Tan WW, Hillman DW, Salim M, Northfelt DW, Anderson DM, Stella PJ, Niedringhaus R, Bernath AM, Gamini SS, Palmieri F, Perez EA. N0332 phase 2 trial of weekly irinotecan hydrochloride and docetaxel in refractory metastatic breast cancer: a North Central Cancer Treatment Group (NCCTG) Trial. Ann Oncol 2009 Jul 22. [Epub ahead of print]
   View PubMed
2. Heath EI, Hillman DW, Vaishampayan U, Sheng S, Sarkar F, Harper F, Gaskins M, Pitot HC, Tan W, Ivy SP, Pili R, Carducci MA, Erlichman C, Liu G. A phase II trial of 17-allylamino-17-demethoxygeldanamycin in patients with hormone-refractory metastatic prostate cancer. Clin Cancer Res 2008 Dec 1; 14(23):7940-6.
   View PubMed
3. Hines SL, Vallow LA, Tan WW, McNeil RB, Perez EA, Jain A. Clinical outcomes after a diagnosis of brain metastases in patients with estrogen- and/or human epidermal growth factor receptor 2-positive versus triple-negative breast cancer. Ann Oncol 2008 Sep; 19(9):1561-5. Epub 2008 Jun 05.
   View PubMed
4. Hines SL, Vallow LA, Tan WW, McNeil RB, Perez EA, Jain A. Clinical outcomes after a diagnosis of brain metastases in patients with estrogen- and/or human epidermal growth factor receptor positive versus triple negative breast cancer. Annals of Oncology 2008 Sep; 19(9).
   View PubMed
5. Pendleton J, Tan WW, Anai S, Chang M, Hou W, Shiverick F, Rosser C. Phase II Trial of Isoflavone in prostate-Specific Antigen Recurrent Prostate Cancer after Previous Local Therapy. BMC Cancer 2008; 8(132) Epub august 2008.
   View PubMed
6. Hines SL, Tan W, Larson JM, Thompson KM, Jorn HK, Files JA. A practical approach to guide clinicians in the evaluation of male patients with breast masses. Geriatrics 2008 Jun; 63(6):19-24.
   View PubMed
7. Coe SG, Tan WW, Fox TP. Cushing's syndrome due to ectopic adrenocorticotropic hormone production secondary to hepatic carcinoid: diagnosis, treatment, and improved quality of life. J Gen Intern Med 2008 Jun; 23(6):875-8. Epub 2008 Apr 02.
   View PubMed
8. Hines SL, Tan W, Larson JM, Thompson KM, Jorn HK, Files JA. A practical approach to guide clinicians in the evaluation of male patients with breast masses. Geriatrics 2008 Jun; 63(6):19-24.
   View PubMed
9. Ames SC, Tan WW, Ames GE, Stone RL, Rizzo TD Jr, Heckman MG, Crook JE, Clark MM, Rummans TA, Werch CE. Quality of life of men with biochemical recurrence of prostate cancer. J Psychosoc Oncol 2008; 26(2):17-34.
   View PubMed
10. Pendleton JM, Tan WW, Anai S, Chang M, Hou W, Shiverick KT, Rosser CJ. Phase II trial of isoflavone in prostate-specific antigen recurrent prostate cancer after previous local therapy. BMC Cancer 2008; 8:132. Epub 2008 May 11.
    View PubMed
11. Coe S, Tan W, Fox T. Cushings' Syndrome Due to Ectopic Adrenocorticotropic Hormone Production Secondary to Hepatic Carcinoid:Diagnosis, Treatment, and Improved Quality of Life. J General Internal Medicine 2008; 23:875-878.
    View PubMed
12. Ames SC, Tan WW, Ames GE, Stone RL, Rizzo TD, Heckman MG, Crook JE, Clark MM, Rummans TA, Werch CE. Quality of life of men with biochemical recurrance of prostate cancer. J Psychosoc Oncol 2008; 26(2):17-34.
    View PubMed
13. Tan W. [Promising new treatment options for metastatic androgen-independent prostate cancer]. Actas Urol Esp 2007 Jun; 31(6):680-5.
    View PubMed
14. Hines SL, Tan WW, Yasrebi M, DePeri ER, Perez EA. The role of mammography in male patients with breast symptoms. Mayo Clin Proc 2007 Mar; 82(3):297-300.
    View PubMed
15. Jatoi A, Burch P, Hillman D, Vanyo JM, Dakhil S, Nikcevich D, Rowland K, Morton R, Flynn PJ, Young C, Tan W, North Central Cancer Treatment Group. A tomato-based, lycopene-containing intervention for androgen-independent prostate cancer: results of a Phase II study from the North Central Cancer Treatment Group. Urology 2007 Feb; 69(2):289-94.
    View PubMed
16. Hines SL, Tan WW, Yasrebi M, DePeri E, Perez E. The Role of Mammography in Male Patients With Breast Symptoms. Mayo Clin Proc 2007; 82(3):297-300.
17. Lee S, Desai KK, Iczkowski KA, Newcomer RG, Wu KJ, Zhao YG, Tan WW, Roycik MD, Sang QX. Coordinated peak expression of MMP-26 and TIMP-4 in preinvasive human prostate tumor. Cell Res 2006 Sep; 16(9):750-8.
    View PubMed
18. Tan WW. Novel agents and targets in managing patients with metastatic prostate cancer. Cancer Control 2006 Jul; 13(3):194-8.
    View PubMed
19. Hughes CL, Tan WW, Ferrone M. Sorafenib for the treatment of renal cell carcinoma. J Pharm Technol 2006; 22(5):281-8.
    View PubMed
20. Hughes C, Tan W, Ferrone M. Sorafenib for the treatment of renal cell Carcinoma. Journal of Pharmacy Technology 2006; 22:281-288.
21. Perez EA, Hillman DW, Fishkin PA, Krook JE, Tan WW, Kuriakose PA, Alberts SR, Dakhil SR. Phase II trial of dolastatin-10 in patients with advanced breast cancer. Invest New Drugs 2005 Jun; 23(3):257-61.
    View PubMed
22. Heath EI, Gaskins M, Pitot HC, Pili R, Tan W, Marschke R, Liu G, Fracasso PM, Hillman D, Sarkar F, Sheng S, Erlichman C, Ivy P. A phase II trial of 17-allylamino-17-demethoxygeldanamycin (17-AAG) in patients with hormone-refractory metastatic prostate cancer. Clin Prostate Cancer 2005; 4:138-41.
    View PubMed
23. Baweja M, Tan W. Bone metastases from Prostate cancer: Known and Novel targets for palliation. Palliative and Supportive Cancer care Journal 2005; 1(2):47-58.
24. Tan M, Tan W. Polypharmacy in the Elders.(CME article) Federal Practitioner 2005; 22(11):76-88.
25. Mincey BA, Tan W. The management of bone loss in patients with breast or prostate cancer. Support Cancer Therapy 2004; 1(3):1-7.
26. Tan M, Tan W. Osteoporosis in prostate cancer(CME Article). Federal Practitioner 2004; 21(12):72-79.
27. Jatoi A, Ellison N, Burch PA, Sloan JA, Dakhil SR, Novotny P, Tan W, Fitch TR, Rowland KM, Young CYF, Flynn PJ. A phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinoma. Cancer 2003 Mar 15; 97(6):1442-6.
    View PubMed
28. Tan WW, Walsh T. Ocular toxicity secondary to paclitaxel in two lung cancer patients. Medical & Pediatric Oncology 1998 Sep; 31(3):177.
    View PubMed
29. Tan W, Herzlich BC, Funaro R, Koutelos K, Pagala M, Amaladevi B, Grob D. Rhabdomyolysis and myoglobinuric acute renal failure associated with classic heat stroke. South Med J 1995 Oct; 88(10):1065-8.
    View PubMed
30. Tan W, Chapnick E, Abter EIM, et al. Paromomycin associated pancreatitis in HIV related cryptosoridiosis. Ann Pharmacother 1995; 29:22-3.
    View PubMed
31. Tan W, Schiano TD, Moss D, Herzlich BC. Hepatic artery aneurysm associated with acute gastroenteritis: successful treatment after intraperitoneal rupture. South Med J 1994 Aug; 87(8):831-2.
    View PubMed
32. Tan W, Chua M. Hemolytic anemia in SLE. The Philippine Journal of Pediatrics 1989; 38(4):255-8.
33. Jatoi A, Burch P, Hillman D, Vanyo JM, Dakhil S, Nikcevich D, Rowland K, Morton R, Flynn PJ, Young C, Tan W. A tomato-based, lycopene-containing intervention for androgen-independent prostate cancer: results of a Phase II study from the North Central Cancer Treatment Group. Urology 2007 Feb; 69(2):289-94.
    View PubMed
34. Amar S, Wu K J, Tan WW. Sorafenib-induced Pancreatitis. Mayo ClinicProc 2007; 82(4):521.
    View PubMed